These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8201659)

  • 1. Re: Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study.
    Pfau A
    J Urol; 1994 Jul; 152(1):173-4. PubMed ID: 8201659
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study.
    Schulman CC; Corbusier A; Michiels H; Taenzer HJ
    J Urol; 1993 Sep; 150(3):917-21. PubMed ID: 8345609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy of urinary tract infections].
    Brühl P; Heinrich J; Hacker J
    Urologe A; 1992 Jan; 31(1):37-42. PubMed ID: 1553803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double-blind, placebo-controlled trial.
    Hachen HJ
    J Urol; 1990 Apr; 143(4):759-62; discussion 762-3. PubMed ID: 2179584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis.
    Naber KG; Cho YH; Matsumoto T; Schaeffer AJ
    Int J Antimicrob Agents; 2009 Feb; 33(2):111-9. PubMed ID: 18963856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial.
    Leitner L; Sybesma W; Chanishvili N; Goderdzishvili M; Chkhotua A; Ujmajuridze A; Schneider MP; Sartori A; Mehnert U; Bachmann LM; Kessler TM
    BMC Urol; 2017 Sep; 17(1):90. PubMed ID: 28950849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial.
    Stapleton A; Latham RH; Johnson C; Stamm WE
    JAMA; 1990 Aug; 264(6):703-6. PubMed ID: 2197450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections.
    Bauer HW; Alloussi S; Egger G; Blümlein HM; Cozma G; Schulman CC;
    Eur Urol; 2005 Apr; 47(4):542-8; discussion 548. PubMed ID: 15774256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial.
    Uehling DT; Hopkins WJ; Balish E; Xing Y; Heisey DM
    J Urol; 1997 Jun; 157(6):2049-52. PubMed ID: 9146577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
    Raz R; Stamm WE
    N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
    Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
    BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of nanoparticles with Escherichia coli receptors for prophylaxis of recurrent urinary tract infections in children.
    Beyitler I; Kavukcu S
    Med Hypotheses; 2017 Feb; 99():67. PubMed ID: 28110702
    [No Abstract]   [Full Text] [Related]  

  • 13. [On antibacterial treatment at the level of the urinary tract: case history, preventive and therapeutic contribution, with nitrofurantoin by oral route].
    MONTALE P; PERIS G; SCARSI GM
    Arch Maragliano Patol Clin; 1962 Apr; 18():299-307. PubMed ID: 14475465
    [No Abstract]   [Full Text] [Related]  

  • 14. [The oral treatment of urogenital trichomoniasis].
    MENDIZABAL AF; OTTURI JE; VIVOLI CA
    Dia Med; 1961 Sep; 33():2165-6. PubMed ID: 14472567
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary tract infections in women. Current unsatisfactory situation and prospects of a new therapeutic concept.
    Rüttgers H; Grischke EM
    Urol Int; 1987; 42(5):342-7. PubMed ID: 3433580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Personal experience with immunotherapy of chronic urinary tract infections using autovaccines].
    Konecný J; Herboczek K; Olsovský Z; Kania A; Smolka J
    Rozhl Chir; 1987 Nov; 66(11):705-9. PubMed ID: 3424011
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
    Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
    J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of recurrent urinary tract infections: efficacy of an orally administered biological response modifier.
    Frey C; Obolensky W; Wyss H
    Urol Int; 1986; 41(6):444-6. PubMed ID: 3547993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones.
    Esposito S; Noviello S; Leone S; Marvaso A; Drago L; Marchetti F;
    J Chemother; 2006 Oct; 18(5):494-501. PubMed ID: 17127226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Evidence on Nonantibiotic Prevention of Recurrent Urinary Tract Infections.
    Kranz J; Schmidt S; Schneidewind L
    Eur Urol Focus; 2019 Jan; 5(1):17-19. PubMed ID: 30292420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.